Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 09, 2023

Chemotherapy Refusal and Subsequent Survival in Older Women With High Genomic Risk Estrogen Receptor–Positive Breast Cancer

Breast Cancer Research and Treatment


Additional Info

Breast Cancer Research and Treatment
Chemotherapy refusal and subsequent survival in healthy older women with high genomic risk estrogen receptor-positive breast cancer
Breast Cancer Res Treat 2023 Jan 24;[EPub Ahead of Print], MJ White, M Kolbow, S Prathibha, C Praska, JS Ankeny, CJ LaRocca, EH Jensen, TM Tuttle, JYC Hui, S Marmor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading